查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997355

内视镜再处理市场：依服务模式、设备类型、产品、最终用户和应用程式划分－2026-2032年全球市场预测

Endoscope Reprocessing Market by Service Model, Device Type, Product, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年内视镜再处理市场价值为 29.5 亿美元，预计到 2026 年将成长至 32.2 亿美元，复合年增长率为 9.68%，到 2032 年将达到 56.4 亿美元。

主要市场统计数据
基准年 2025 29.5亿美元
预计年份：2026年 32.2亿美元
预测年份：2032年 56.4亿美元
复合年增长率 (%) 9.68%

本文简要概述了内视镜再处理流程。文章重点介绍了影响器械消毒和生命週期管理的临床安全要求、操作复杂性和战略重点。

内视镜再处理涉及临床安全、监管严格性和营运效率的三个面向。医疗机构和服务供应商必须管理复杂器材的库存，同时确保所有投入临床使用的软式和硬式内视镜均无生物污染，并透过检验的流程实现可追溯性。近年来，随着人们对感染传播、器械复杂性和交叉感染风险的日益关注，再处理已从单纯的后台操作转变为保障病患安全的一项策略性要求。这迫使医院和门诊中心重新思考其工作流程、器械选择和供应商关係。

分析自动化、监管加强和服务模式的演变如何重新定义内视镜再处理的操作标准、合规要求和技术采用。

内视镜再处理领域正经历一系列变革，其驱动力包括技术成熟、监管力度加大以及服务模式的演变。自动化和设备进步降低了人工操作的差异性，实现了高处理能力和一致的检验记录，从而重新定义了处理时间和人员配置模式。同时，软式内视镜（尤其是那些具有复杂通道和升降机构的内视镜）日益复杂，使得人们对再处理剂和机械清洁流程的有效性更加关注，这要求製造商和服务供应商针对特定器械制定创新的通讯协定。

我们将检验研究关税变化和贸易政策转变如何影响再加工设备和耗材的采购选择、供应连续性和生命週期成本考量。

关税调整和贸易政策变化正对整个再处理设备及配件供应链的设备采购、耗材定价和供应商选择策略产生实际影响。资本设备、替换零件和化学耗材关税的变化导致关键零件的采购成本增加和前置作业时间改变，这可能会促使采购者重新评估其供应商多元化策略。为此，采购团队正在进行详细的服务交付成本分析和供应合约压力测试，以确保服务的连续性并满足灭菌和清洁要求。

以细分为导向的全面观点服务模式、医疗设备分类、临床环境、治疗应用和产品系列与营运和采购重点连结起来。

细分市场分析揭示了服务模式、医疗设备分类、终端用户环境、临床应用和产品类别如何共同影响采购优先顺序和营运流程。在基于服务模式进行评估时，各机构会区分内部灭菌和外包给第三方服务供应商两种方式。每种方式在资本投入、人员配备和品管方面都有不同的要求。器械类型的检验突显了软式内视镜内视镜和硬式内视镜在要求上的差异。软式内视镜，例如支气管镜、大肠镜、十二指肠镜、胃镜和输尿管镜，通常需要复杂的管腔冲洗和检验的清洁剂。关节镜、膀胱镜和腹腔镜，则往往具有不同的清洁网路基地台和再处理週期特性。

本研究对美洲、欧洲、中东和非洲以及亚太地区的采用驱动因素、监管预期和供应链趋势进行了区域分析，揭示了部署中使用的战略意义。

区域趋势对技术采纳模式、监管预期和供应商生态系统有显着影响。在美洲，医疗保健系统日益重视遵守国家感染控制标准、快速采用自动化技术以及集中消毒，以提高整个医院网路的运作效率。供应链的应对力以及与製造商和分销商的地理位置接近性通常会影响大型备件和常用耗材的库存策略，而区域监管指南则会影响检验和文件记录实践。

对领先供应商如何将硬体、耗材和数位可追溯性整合到统一、检验的工作流程和服务模式中，以满足买家需求进行策略分析。

医疗器材再处理生态系统中的主要企业正致力于开发整合解决方案，将经过检验的资本设备、耗材和数位化可追溯性相结合，从而在安全性和流程控制方面实现可衡量的改进。策略重点包括推动再处理流程的自动化，改善复杂内视镜的特定清洁通讯协定，以及拓展服务范围，例如託管式再处理和集中式灭菌，以实现生命週期价值。器械製造商与第三方服务机构之间的合作日益普遍，从而能够提供捆绑式服务，简化医疗系统的采购和营运流程。

可操作且优先的行动，帮助决策者整合自动化、员工能力、采购弹性和数位可追溯性，以形成一致的再加工策略，进而降低风险。

产业领导者应推动一系列协调一致的倡议，以整合技术应用、营运管治和人力资源能力。优先投资自动化和检验的资本设备，以减少人为操作差异，并创建一致的流程文檔，从而支援符合认证和审核要求。除了设备升级外，还应为灭菌人员实施严格的能力发展计划，利用基于模拟的培训和能力指标来灌输最佳实践并减少再处理错误。

这清楚地概述了一种混合方法研究途径，该方法结合了专家访谈、技术咨询和二手分析，从而确保在各个细分领域检验且可操作的见解。

本研究途径结合了结构化的初步研究、行业专家访谈和系统的二次分析，旨在建立可靠且可操作的知识库。初步调查方法包括对消毒管理人员、临床主任、采购专家和第三方服务提供者进行深入访谈，以了解实际限制、技术评估标准和采购因素。此外，还透过与产品工程师和验证专家的技术咨询，补充这些定性信息，从而详细揭示设备的再处理挑战和性能特征。

这份简明扼要的摘要将再处理定位为系统层面的优先事项。持续投资于设备、耗材、培训和可追溯性将显着提升安全性和韧性。

内视镜再处理不再只是后台技术工作，而是现代医疗服务中具有战略意义且符合合规主导。投资于检验的自动化系统、可靠的耗材以及全面的员工能力发展计划的医疗机构，在控制感染风险、维持处理能力和确保合规性方面更具优势。区域和产业趋势持续影响筹资策略，而供应链的韧性和与供应商的协作是长期营运规划的关键要素。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 工业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜再处理市场：依服务模式划分

  • 内部处理
  • 外包

第九章 内视镜再处理市场：依设备类型划分

  • 柔软的
    • 支气管镜检查
    • 大肠镜检查
    • 十二指肠镜
    • 胃镜检查
    • 输尿管镜
  • 难的
    • 关节镜
    • 膀胱镜
    • 腹腔镜

第十章 内视镜再处理市场：依产品划分

  • 资本设备
    • 自动内视镜再处理装置
    • 烘干柜
    • 消毒器
  • 耗材和配件
    • 清洁剂
    • 酵素清洁剂
    • 润滑剂
    • 消毒配件

第十一章 内视镜再处理市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 诊断中心
  • 医院

第十二章 内视镜再处理市场：依应用领域划分

  • 胃肠内视镜检查
  • 腹腔镜
  • 肺科
  • 泌尿系统

第十三章 内视镜再处理市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜再处理市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜再处理市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国内视镜再处理市场

第十七章：中国内视镜再处理市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • 3M Company
  • Advanced Sterilization Products, Inc.
  • Belimed AG
  • Cantel Medical Corporation
  • Ecolab Inc.
  • Fujifilm Holdings Corporation
  • Getinge AB
  • HOYA Corporation
  • Karl Storz SE & Co. KG
  • Olympus Corporation
  • Scil Technology Ltd
  • Shinva Medical Instrument Co., Ltd.
  • Steelco SpA
  • STERIS plc
  • Wassenburg Medical BV
Product Code: MRR-50124643627B

The Endoscope Reprocessing Market was valued at USD 2.95 billion in 2025 and is projected to grow to USD 3.22 billion in 2026, with a CAGR of 9.68%, reaching USD 5.64 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.95 billion
Estimated Year [2026] USD 3.22 billion
Forecast Year [2032] USD 5.64 billion
CAGR (%) 9.68%

A concise orientation to endoscope reprocessing that frames clinical safety imperatives, operational complexity, and the strategic priorities shaping instrument decontamination and device lifecycle management

Endoscope reprocessing sits at the intersection of clinical safety, regulatory rigor, and operational efficiency. Healthcare facilities and service providers must manage complex instrument inventories while ensuring that each flexible or rigid endoscope introduced into care pathways is free of biological contaminants and traceable through validated processes. In recent years, concerns about infection transmission, device complexity, and cross-contamination risks have elevated reprocessing from a back-of-house activity to a strategic patient-safety imperative, prompting hospitals and ambulatory centers to re-examine workflows, equipment selection, and supplier relationships.

Consequently, healthcare leaders are prioritizing investments that reduce variability, shorten turnaround times, and deliver demonstrable compliance with evolving standards. The technical demands of automated reprocessors, thorough drying and storage solutions, and consumable chemistries now coexist with operational constraints such as staff skill gaps and high throughput requirements. Stakeholders face a multifaceted problem set where clinical outcomes, workflow resilience, and total cost of operation must be balanced. To navigate these pressures, decision-makers require clear criteria to evaluate technologies, service models, and protocols that improve decontamination reliability without compromising capacity or increasing staff burden.

This introduction frames the core themes that recur throughout the analysis: device complexity, regulatory expectations, workforce capability, and the imperative for traceable, validated processes that uphold patient safety while supporting service delivery

An analysis of how automation, regulatory reinforcement, and service model evolution are redefining operational standards, compliance expectations, and technology adoption across endoscope reprocessing

The landscape of endoscope reprocessing is undergoing a series of transformative shifts driven by technology maturation, heightened regulatory scrutiny, and evolving service delivery paradigms. Automation and instrumentation advances are reducing manual variability and enabling higher throughput with consistent validation records, which in turn reshape expectations for turnaround time and staffing models. Simultaneously, the complexity of flexible endoscopes-especially those with intricate channels and elevator mechanisms-has increased scrutiny on the effectiveness of reprocessing chemistries and mechanical cleaning steps, prompting both manufacturers and service providers to innovate around device-specific protocols.

Regulatory bodies and accreditation organizations are reinforcing standards for traceability, device validation, and staff competency, which has elevated the role of digital documentation and process monitoring in routine operations. As a result, providers are integrating information systems that capture device histories, maintenance records, and reprocessing logs to demonstrate compliance and enable root-cause analysis when incidents occur. Third-party service providers and centralized sterile processing units are gaining traction as health systems seek scale efficiencies, but this shift also increases the need for robust supply chains and transparent service-level agreements.

Finally, sustainability and single-use debate are introducing new vectors of decision-making: lifecycle impacts, waste management, and the balance between disposables and reusable equipment influence procurement and clinical guidelines. These converging trends are accelerating innovation while compelling organizations to adopt more rigorous, system-level approaches to reprocessing governance

A focused review of how tariff changes and trade policy shifts are influencing procurement choices, supply continuity, and lifecycle cost considerations for reprocessing equipment and consumables

Tariff adjustments and trade policy shifts have tangible effects on equipment sourcing, consumable pricing, and vendor selection strategies across the supply chain for reprocessing equipment and accessories. Changes in duties on capital equipment, replacement parts, and chemical consumables can increase procurement costs, alter lead times for critical components, and prompt buyers to re-evaluate supplier diversification strategies. In response, procurement teams are conducting granular cost-to-serve analyses and stress-testing supply agreements to ensure continuity of service and maintain compliance with sterilization and cleaning requirements.

These trade dynamics often catalyze closer collaboration between device manufacturers, regional distributors, and health system purchasing groups to mitigate exposure to import-related cost volatility. Some organizations are responding by negotiating longer-term contracts, localizing inventories of high-use consumables, or qualifying alternative suppliers to preserve operational resilience. At the same time, developers of automated reprocessors and ancillary capital equipment are adjusting product roadmaps, component sourcing plans, and aftermarket support models to reduce vulnerability to tariff-induced cost increases.

The cumulative effect is a heightened focus on total lifecycle procurement strategies that account for cross-border cost pressures while safeguarding clinical performance and supply continuity. Operational leaders should therefore integrate tariff scenario planning into capital investment decisions and consumables sourcing to avoid unexpected disruptions to reprocessing workflows

A comprehensive segmentation-driven perspective linking service models, device classes, clinical settings, procedural applications, and product families to operational and procurement priorities

Segmentation analysis reveals how service model, device taxonomy, end-user environment, clinical application, and product class combine to shape procurement priorities and operational workflows. When evaluating by service model, organizations distinguish between maintaining in-house sterile processing versus outsourcing to third-party service providers, each approach presenting different demands for capital investment, staffing, and quality oversight. Examining device type highlights the divergent requirements of flexible and rigid endoscopes: flexible instruments include bronchoscope, colonoscope, duodenoscope, gastroscope, and ureteroscope variants that often require intricate channel cleaning and validated chemistries, while rigid instruments such as arthroscope, cystoscope, and laparoscope tend to have different cleaning access points and reprocessing cycle profiles.

End-user considerations further refine priorities across ambulatory surgical centers, clinics, diagnostic centers, and hospitals, where throughput, case mix, and regulatory obligations vary significantly. Application-driven segmentation indicates procedural domains-gastrointestinal endoscopy, laparoscopy, pulmonology, and urology-each with specific device usage patterns and infection-prevention sensitivities that influence selection of reprocessing techniques and consumable chemistries. Product-level segmentation distinguishes capital equipment from consumables and accessories: capital items include automated endoscope reprocessors, drying cabinets, and sterilizers that anchor process validation and facility layout, while consumables and accessories encompass detergents, enzymatic cleaners, lubricants, and sterilization accessories that determine daily operating practice.

Taken together, these strata form a multidimensional market map that clarifies where innovation and investment deliver the most operational leverage, and where tailored training, validation protocols, and service contracts are required to support safe, efficient instrument reuse

A regional analysis that contrasts adoption drivers, regulatory expectations, and supply chain dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific to reveal strategic implications for deployment

Regional dynamics materially influence technology adoption patterns, regulatory expectations, and supplier ecosystems. In the Americas, health systems emphasize compliance with national infection-prevention standards, rapid technology adoption for automation, and growing interest in centralized sterile processing to drive operational efficiencies across hospital networks. Supply chain responsiveness and proximity to manufacturers or distributors often shape stocking strategies for capital spare parts and high-use consumables, while regional regulatory guidance informs validation and documentation practices.

In Europe, Middle East & Africa, regulatory harmonization across multiple jurisdictions, varying reimbursement models, and a heightened focus on lifecycle environmental impacts drive distinct procurement and usage patterns. Facilities frequently weigh environmental considerations alongside clinical effectiveness when assessing single-use versus reusable components, and cross-border supplier relationships can be influenced by regional trade agreements and logistical constraints.

In Asia-Pacific, rapid healthcare infrastructure expansion, increasing investments in tertiary care capacity, and varied regulatory maturity levels produce a fragmented but innovation-ready environment. Buyers in this region often prioritize scalable automation and workforce training solutions to meet growing procedural volumes, while manufacturers and service providers adapt product features and support models to accommodate diverse facility types and regional service delivery constraints. Across all regions, local regulatory guidance, procurement frameworks, and the availability of qualified service partners remain decisive factors when organizations select reprocessing technologies and consumable portfolios

A strategic account of how leading suppliers are converging hardware, consumables, and digital traceability into integrated validated workflows and service models to meet purchaser demands

Leading firms in the reprocessing ecosystem are concentrating on integrated solutions that combine validated capital equipment, consumable chemistries, and digital traceability to deliver measurable improvements in safety and process control. Strategic priorities for companies include advancing automation in reprocessing cycles, enhancing device-specific cleaning protocols for complex endoscopes, and expanding service offerings such as managed reprocessing and centralized sterilization to capture lifecycle value. Partnerships between equipment manufacturers and third-party service organizations are increasingly common, enabling bundled offerings that simplify procurement and operation for health systems.

Innovation pipelines emphasize ease-of-use, interoperability with facility IT systems, and robust validation data to support regulatory compliance and purchaser confidence. Consumable manufacturers are refining enzymatic formulations and lubricants to improve cleaning efficacy and reduce process variability, while makers of drying cabinets and sterilizers focus on cycle documentation and material compatibility. Additionally, aftermarket support and education services have become a differentiator, as hospitals demand reliable training programs and rapid technical assistance to maintain throughput and minimize downtime.

Competition is shifting from discrete product features toward comprehensive, validated workflows that reduce risk and administrative burden for clinical teams. As a result, companies that can demonstrate seamless integration of hardware, software, and consumables alongside responsive service models are positioned to lead in markets where institutional quality and traceability are non-negotiable

Practical and prioritized actions for decision-makers to align automation, workforce competency, procurement resilience, and digital traceability into a cohesive reprocessing strategy that reduces risk

Industry leaders should pursue a coordinated set of initiatives that align technology adoption with operational governance and workforce capability. Prioritize investments in automation and validated capital equipment to reduce manual variability and generate consistent process documentation that supports accreditation and audit readiness. Complement equipment upgrades with rigorous competency programs for sterile processing staff, leveraging simulation-based training and proficiency metrics to embed best practices and reduce reprocessing errors.

Strengthen supplier relationships by negotiating service-level agreements that include rapid parts availability, preventive maintenance, and training commitments, while diversifying sources for critical consumables to mitigate supply-chain disruptions. Implement digital traceability systems that integrate with electronic health records and asset management platforms to capture device histories, reprocessing cycles, and maintenance records, enabling faster root-cause analysis and regulatory reporting. Evaluate opportunities for centralized or third-party reprocessing where scale efficiencies can improve throughput and standardization, but ensure contracts specify quality control metrics and transparency in processes.

Finally, incorporate environmental and lifecycle assessments into procurement decisions to balance clinical efficacy with sustainability objectives, and maintain an active program for regulatory surveillance to anticipate standard changes. By aligning capital, consumables, training, and data strategies, leaders can build resilient, compliant reprocessing operations that support both patient safety and operational performance

A transparent overview of the mixed-method research approach combining expert interviews, technical consultations, and secondary analysis to ensure validated and actionable findings across discrete segments

The research approach combines structured primary engagement with domain experts and disciplined secondary analysis to generate a reliable, actionable intelligence base. Primary methods include in-depth interviews with sterile processing managers, clinical leads, procurement specialists, and third-party service operators to capture real-world operational constraints, technology evaluation criteria, and procurement drivers. These qualitative inputs are complemented by technical consultations with product engineers and validation specialists to detail device-specific reprocessing challenges and equipment performance attributes.

Secondary analysis leverages publicly available regulatory guidance, clinical best-practice documents, product literature, and case studies to map technology features and process requirements. Data triangulation reconciles interview insights with product specifications and documented standards to identify consistent patterns and areas of divergence. Segmentation frameworks were applied across service model, device type, end-user setting, clinical application, and product class to ensure that findings are relevant to distinct decision contexts.

The methodology emphasizes transparency in assumptions, traceability of data sources, and limitations such as jurisdictional variability in regulation and the evolving nature of device designs. Where appropriate, sensitivity checks were performed to validate that strategic recommendations hold under alternate operational scenarios. This structured approach ensures recommendations are grounded in practitioner experience, technical detail, and cross-validated evidence

A concise synthesis that frames reprocessing as a systems-level priority where aligned investments in equipment, consumables, training, and traceability yield measurable improvements in safety and resilience

Endoscope reprocessing is no longer solely a technical backroom function but a strategic, compliance-driven component of modern healthcare delivery. Facilities that invest in validated automation, robust consumable chemistries, and comprehensive staff competency programs are better positioned to control infection risk, maintain throughput, and demonstrate regulatory compliance. Regional and trade dynamics continue to shape procurement strategies, making supply-chain resilience and supplier collaboration essential elements of long-term operational planning.

The most impactful improvements arise when organizations treat reprocessing as an end-to-end system: capital equipment, consumables, digital traceability, workforce training, and service partnerships must be aligned to produce repeatable, auditable outcomes. Industry participants-manufacturers, service providers, and health systems-are responding by developing integrated offerings that emphasize interoperability, documentation, and validated workflows. Moving forward, leaders will need to balance immediate operational gains with considerations for sustainability and adaptability to evolving device designs and regulatory expectations.

Ultimately, success depends on adopting a systems perspective that prioritizes patient safety, process reliability, and procurement resilience. Those who embed this perspective into purchasing, staffing, and quality frameworks will realize sustained benefits in clinical outcomes and operational stability

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscope Reprocessing Market, by Service Model

  • 8.1. In-House
  • 8.2. Third Party

9. Endoscope Reprocessing Market, by Device Type

  • 9.1. Flexible
    • 9.1.1. Bronchoscope
    • 9.1.2. Colonoscope
    • 9.1.3. Duodenoscope
    • 9.1.4. Gastroscope
    • 9.1.5. Ureteroscope
  • 9.2. Rigid
    • 9.2.1. Arthroscope
    • 9.2.2. Cystoscope
    • 9.2.3. Laparoscope

10. Endoscope Reprocessing Market, by Product

  • 10.1. Capital Equipment
    • 10.1.1. Automated Endoscope Reprocessors
    • 10.1.2. Drying Cabinets
    • 10.1.3. Sterilizers
  • 10.2. Consumables And Accessories
    • 10.2.1. Detergents
    • 10.2.2. Enzymatic Cleaners
    • 10.2.3. Lubricants
    • 10.2.4. Sterilization Accessories

11. Endoscope Reprocessing Market, by End User

  • 11.1. Ambulatory Surgical Center
  • 11.2. Clinic
  • 11.3. Diagnostic Center
  • 11.4. Hospitals

12. Endoscope Reprocessing Market, by Application

  • 12.1. Gastrointestinal Endoscopy
  • 12.2. Laparoscopy
  • 12.3. Pulmonology
  • 12.4. Urology

13. Endoscope Reprocessing Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscope Reprocessing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscope Reprocessing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscope Reprocessing Market

17. China Endoscope Reprocessing Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. 3M Company
  • 18.6. Advanced Sterilization Products, Inc.
  • 18.7. Belimed AG
  • 18.8. Cantel Medical Corporation
  • 18.9. Ecolab Inc.
  • 18.10. Fujifilm Holdings Corporation
  • 18.11. Getinge AB
  • 18.12. HOYA Corporation
  • 18.13. Karl Storz SE & Co. KG
  • 18.14. Olympus Corporation
  • 18.15. Scil Technology Ltd
  • 18.16. Shinva Medical Instrument Co., Ltd.
  • 18.17. Steelco S.p.A.
  • 18.18. STERIS plc
  • 18.19. Wassenburg Medical B.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPE REPROCESSING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPE REPROCESSING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY IN-HOUSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY THIRD PARTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY BRONCHOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COLONOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DUODENOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY URETEROSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ARTHROSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CYSTOSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AUTOMATED ENDOSCOPE REPROCESSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DRYING CABINETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DETERGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY ENZYMATIC CLEANERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LUBRICANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY STERILIZATION ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY DIAGNOSTIC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GASTROINTESTINAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY LAPAROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY PULMONOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 194. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 195. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 196. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 197. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 198. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. GCC ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 228. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. G7 ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 238. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 239. NATO ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ENDOSCOPE REPROCESSING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY SERVICE MODEL, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY FLEXIBLE, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY RIGID, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY CAPITAL EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY CONSUMABLES AND ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA ENDOSCOPE REPROCESSING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)